Tag Archives: Asuragen

AUSTIN, Texas — Asuragen, Inc., a leading molecular diagnostic company, has been selected to work with the Early Diagnosis Consortium (EDC), a collaboration between Cancer Research UK, Cancer Research Technology, and Abcodia. The Consortium aims to discover and validate serum biomarkers ...

Title – NGS Lessons in Translational Diagnostics: Mining and Migrating Robust Cancer Biomarkers to Unified DNA and RNA NGS Panels Date – September 10, 2014 Time – 1:00pm Eastern Time In this webinar, a comprehensive approach for NGS-based biomarker discovery ...